Combined with prior evidence that EGCG and SMRR ameliorate obesity-associated inflammation and lipid accumulation, these findings suggest that their anti-obesity effects may be mediated, at least in part, through modulation of the DAP12–SYK pathway in adipose tissue macrophages. The gene discussed is SYK; the disease is obesity disorder.